Search results
FX Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVIII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVII Inhibitor Plasma (2) Moderate (11-50 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
HEMOCLOT Quanti. V-L
Quantitative measurement of Factor V Leiden, resistant to the action of activated protein C (APC resistance), for diagnosing patients carrying the R506Q FV mutation (Factor V Leiden), or any FV mutant resistant to APC.
HEMOCLOT DTI 2.5 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
HEMOCLOT DTI 1 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
BIOPHEN Protein C (LRT, Liquid Reagent Technology)
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
BIOPHEN Protein C 5
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
Fibrinogen Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human fibrinogen deficient plasma is required.
Fibrinogen, anti-human, mouse, IgG